Hcw biologics is granted second fundamental patent: u.s. patent for multi-chain chimeric polypeptide created with tobi™ platform

Allowed claims for novel immunotherapeutic compound constructed with tissue factor as platform for target binding domains

HCWB Ratings Summary

HCWB Quant Ranking